Bio-K+ 50 Billion
Natural health product licensed in Canada
- Other names
- ANTIBIO PRO, IBS PRO
- Licence holder
- Kerry (Canada) Inc.
- NPN or DIN-HM
- 80015104
- Status
- Active licence
- Licence date
- 30 September 2009
- Revision date
- 21 October 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Probiotic blend Source : Lbc80r Potency : 0 Lactobacillus acidophilus CL1285 | 50 Milliards d'UFC | Not calculated |
| Probiotic blend Source : CLR2 Potency : 0 Lactobacillus acidophilus CL1285 | 50 Milliards d'UFC | Not calculated |
| Probiotic blend Source : CL 1285 Potency : 0 Lactobacillus acidophilus CL1285 | 50 Milliards d'UFC | Not calculated |
| Probiotic blend Source : Lbc80r Potency : 0 Lactobacillus casei LBC80R | Not specified | Not calculated |
| Probiotic blend Source : CLR2 Potency : 0 Lactobacillus casei LBC80R | Not specified | Not calculated |
| Probiotic blend Source : CL 1285 Potency : 0 Lactobacillus casei LBC80R | Not specified | Not calculated |
| Probiotic blend Source : Lbc80r Potency : 0 Lactobacillus rhamnosus CLR2 | Not specified | Not calculated |
| Probiotic blend Source : CLR2 Potency : 0 Lactobacillus rhamnosus CLR2 | Not specified | Not calculated |
| Probiotic blend Source : CL 1285 Potency : 0 Lactobacillus rhamnosus CLR2 | Not specified | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Hypromellose, Acide ascorbique, Maltodextrine, Gomme de gellane, Ethylcellulose, triglycérides à chaînes moyennes, extrait de levure, cellulose, Stéarate de magnésium, Ascorbate de sodium, Alginate de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 13 years ; maximum: 17 years | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
| Adultes | minimum: 18 years | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 12 years | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
1-Helps to reduce the risk of antibiotic associated diarrhea 2-Helps to reduce the risk of Clostridium Difficile associated diarrhea (CDAD) in hospitalized patients 3-Helps support intestinal/gastrointestinal health 4-Could promote a favorable gut flora 5-Helps improve quality of lifef in people with diarrhea-predominant irritable bowel syndrome
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80015104
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.